1-5 of 5
Monika Brüggemann
Close
Sort by
Journal Articles

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods

Michaela Kotrová, Johannes Koopmann, Heiko Trautmann, Nael Alakel, Joachim Beck, Kathrin Nachtkamp, Björn Steffen, Simon Raffel, Andreas Viardot, Klaus Wethmar, Nikos Darzentas, Claudia D. Baldus, Nicola Gökbuget, Monika Brüggemann
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3006–3010.
https://doi.org/10.1182/bloodadvances.2021006727
Published: 2022
Includes: Supplemental data
Journal Articles

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

James Peter Stewart, Jana Gazdova, Nikos Darzentas, Dörte Wren, Paula Proszek, Grazia Fazio, Simona Songia, Miguel Alcoceba, Maria Eugenia Sarasquete, Patrick Villarese, Michèle Y. van der Klift, Kim C. Heezen, Neil McCafferty, Karol Pal, Mark Catherwood, Chang Sik Kim, Shambhavi Srivastava, Leonie I. Kroeze, Elizabeth Hodges, Kostas Stamatopoulos, Wolfram Klapper, Elisa Genuardi, Simone Ferrero, Michiel van den Brand, Giovanni Cazzaniga, Frederic Davi, Lesley-Ann Sutton, Ramon Garcia-Sanz, Patricia J. T. A. Groenen, Elizabeth A. Macintyre, Monika Brüggemann, Christiane Pott, Anton W. Langerak, David Gonzalez, on behalf of the EuroClonality-NGS Working Group
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3188–3198.
https://doi.org/10.1182/bloodadvances.2020004056
Published: 2021
Includes: Supplemental data
Journal Articles

The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL

Beat Bornhauser, Gunnar Cario, Anna Rinaldi, Thomas Risch, Virginia Rodriguez Martinez, Moritz Schütte, Hans-Jörg Warnatz, Nastassja Scheidegger, Paulina Mirkowska, Martina Temperli, Claudia Möller, Angela Schumich, Michael Dworzak, Andishe Attarbaschi, Monika Brüggemann, Mathias Ritgen, Ester Mejstrikova, Andreas Hofmann, Barbara Buldini, Pamela Scarparo, Giuseppe Basso, Oscar Maglia, Giuseppe Gaipa, Tessa Lara Skroblyn, Quy A. Ngo, Geertruij te Kronnie, Elena Vendramini, Renate Panzer-Grümayer, Malwine Jeanette Barz, Blerim Marovca, Mathias Hauri-Hohl, Felix Niggli, Cornelia Eckert, Martin Schrappe, Martin Stanulla, Martin Zimmermann, Bernd Wollscheid, Marie-Laure Yaspo, Jean-Pierre Bourquin
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4052–4064.
https://doi.org/10.1182/bloodadvances.2019000938
Published: 2020
Includes: Supplemental data
Journal Articles

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Clinical Trials & Observations
Nicola Gökbuget, Hagop M. Kantarjian, Monika Brüggemann, Anthony S. Stein, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard Heffner, Françoise Rigal-Huguet, Mark Litzow, Susan O’Brien, Gerhard Zugmaier, Shan Gao, Dirk Nagorsen, Stephen J. Forman, Max S. Topp
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3033–3037.
https://doi.org/10.1182/bloodadvances.2019000457
Published: 2019
Includes: Supplemental data
Journal Articles

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Monika Brüggemann, Michaela Kotrova
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2456–2466.
https://doi.org/10.1182/bloodadvances.2017009845
Published: 2017